There's cautious optimism among Alzheimer's experts here - after the first new treatment for the disease in nearly 20 years was approved by US regulators.
The new drug is supposed to slow the progression of the disease in those in the early stages - but clinical trials haven't yet proven its effectiveness.
Eleisha Foon reports.
